| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.01 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |